Gossamer Bio (GOSS) Non-Current Debt (2019 - 2023)
Gossamer Bio (GOSS) posted Non-Current Debt of $814000.0 for Q4 2023, down 77.6% on a QoQ basis from $3.6 million in Q3 2023, and down 93.21% year-over-year from $12.0 million in Q4 2022.
Analysis
Gossamer Bio (GOSS) Non-Current Debt (2019 - 2023) Analysis & Trends
Gossamer Bio has reported Non-Current Debt for 5 years, with the latest figure at $814000.0 in Q4 2023.
- On a quarterly basis, Non-Current Debt fell 93.21% year-over-year to $814000.0 in Q4 2023; TTM through Dec 2023 was $814000.0, a 93.21% decrease from a year earlier, with the FY2023 full-year figure at $814000.0, down 93.21% from the prior year.
- Non-Current Debt was $814000.0 for Q4 2023 at Gossamer Bio, down from $3.6 million in the prior quarter.
- The five-year high for Non-Current Debt was $29.2 million in Q1 2022, with the low at $814000.0 in Q4 2023.
- Average Non-Current Debt over 5 years is $21.5 million, with a median of $28.5 million recorded in 2019.
- The sharpest annual moves came in 2020 and 2023: Non-Current Debt rose 1.26% in 2020, then sank 93.21% in 2023.
- Over 5 years, Non-Current Debt stood at $28.5 million in 2019, then advanced by 1.0% to $28.7 million in 2020, then rose by 1.17% to $29.1 million in 2021, then plunged by 58.77% to $12.0 million in 2022, then tumbled by 93.21% to $814000.0 in 2023.
- The last three Non-Current Debt figures came in at $814000.0 (Q4 2023), $3.6 million (Q3 2023), and $6.4 million (Q2 2023), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Non-Current Debt (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 641.22 Bn | 620.47 Bn | 17.26 Bn | 37.34 Bn |
| 2 | AbbVie | 446.28 Bn | 439.71 Bn | 12.70 Bn | 62.48 Bn |
| 3 | Merck | 357.56 Bn | 350.42 Bn | 12.21 Bn | 51.08 Bn |
| 4 | Novartis Ag | 268.11 Bn | 260.42 Bn | 11.24 Bn | - |
| 5 | Pfizer | 156.86 Bn | 145.17 Bn | 10.94 Bn | 60.50 Bn |
| 6 | Sanofi | 52.10 Bn | 44.72 Bn | 10.79 Bn | 17.02 Bn |
| 7 | Revolution Medicines | 43.01 Bn | 43.01 Bn | - | - |
| 8 | Incyte | 24.82 Bn | 20.28 Bn | 1.57 Bn | - |
| 9 | United Therapeutics | 21.39 Bn | 18.73 Bn | 683.80 Mn | - |
| 10 | Gossamer Bio | 45.60 Mn | -11.42 Mn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2023 | 814,000.00 |
| Sep 30, 2023 | 3.63 Mn |
| Jun 30, 2023 | 6.44 Mn |
| Mar 31, 2023 | 9.22 Mn |
| Dec 31, 2022 | 11.99 Mn |
| Sep 30, 2022 | 14.83 Mn |
| Jun 30, 2022 | 17.65 Mn |
| Mar 31, 2022 | 29.17 Mn |
| Dec 31, 2021 | 29.08 Mn |
| Sep 30, 2021 | 28.99 Mn |
| Jun 30, 2021 | 28.91 Mn |
| Mar 31, 2021 | 28.82 Mn |
| Dec 31, 2020 | 28.74 Mn |
| Sep 30, 2020 | 28.67 Mn |
| Jun 30, 2020 | 28.64 Mn |
| Mar 31, 2020 | 28.55 Mn |
| Dec 31, 2019 | 28.46 Mn |
| Sep 30, 2019 | 28.37 Mn |
| Jun 30, 2019 | 28.28 Mn |